STRUCTURAL BASIS OF CD28 REGULATION OF LUNG INFLAMMATION
CD28 调节肺部炎症的结构基础
基本信息
- 批准号:6629025
- 负责人:
- 金额:$ 33.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-15 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the Applicant's Abstract): T lymphocytes are a major
component of the inflammatory response and aberrant regulation of T cell
activation and differentiation may be central to the pathogenesis of asthma.
The CD28 co-stimulatory receptor is a critical regulator of T cell activation
and differentiation, and thus may be an important target for therapy of immune
mediated diseases. Manipulation of this receptor has been shown to alter the
course of several animal models of disease, inducing models of antigen-induced
airway inflammation. Accordingly, the primary goal of this proposal is to
increase our understanding of the cellular and molecular basis by which CD28
modulates the T cell response to antigen. CD28 regulates multiple aspects of T
cell functions, including proliferation, adhesion, T helper cell phenotype
development and cell survival. The PI demonstrates that CD28 is essential for
the development of antigen-induced inflammation in a murine model of airway
disease. Sensitized CD28-deficient mice fail to develop airway inflammation or
eosinophilia in response to antigen challenge. Examination of T helper cell
phenotype in CD28 -/- mice demonstrates a defect in Th2 cytokine gene
expression. The mechanism by which CD28 regulates these diverse aspects of T
cell function is poorly understood, but likely involves multiple signaling
pathways. Studies in transformed cell lines have implicated specific domains in
the cytoplasmic trail of CD28 as important in signaling, but no consensus
exists as to what is required for CD28 function in primary cells or in vivo
responses. The data in primary T cells demonstrates a requirement for specific
proline mediated interactions with the non-receptor tyrosine kinase lck in the
regulation of T cell proliferation by CD28. The PI hypothesizes that multiple
distinct structural domains of CD28 modulate specific features of T cell
activation and differentiation. To address this, the following specific aims
have been proposed: 1) determine the structural features of CD28 required for
co-stimulation of primary T cells in vitro; and 2) characterize the specific
cellular and molecular determinants by which CD28 regulates airway inflammation
in vivo. These studies will provide critical data as to the regulation of T
cell directed immune responses, and provide a rational basis for the
development of new therapeutic strategies in the treatment of inflammatory lung
disease.
描述:(改编自申请人的摘要):T淋巴细胞是主要的
T细胞的炎症反应和异常调节的成分
激活和分化可能是哮喘发病机理的核心。
CD28共刺激受体是T细胞激活的关键调节剂
和分化,因此可能是治疗免疫的重要靶标
介导的疾病。该受体的操作已显示出改变
几种疾病动物模型的过程,诱导抗原诱导的模型
气道炎症。因此,该提议的主要目标是
提高我们对CD28的细胞和分子基础的理解
调节T细胞对抗原的反应。 CD28调节t的多个方面
细胞功能,包括增殖,粘附,T辅助细胞表型
发育和细胞存活。 PI证明CD28对于
在气道的鼠模型中,抗原引起的炎症的发展
疾病。敏化的CD28缺陷小鼠无法发展出气道炎症或
嗜酸性粒细胞响应抗原挑战。 T辅助细胞检查
CD28 - / - 小鼠中的表型显示了Th2细胞因子基因的缺陷
表达。 CD28调节T的机制
细胞功能知之甚少,但可能涉及多个信号
途径。转化的细胞系的研究已暗示了特定领域
CD28的细胞质轨迹在信号传导中很重要,但无共识
存在原代细胞或体内CD28功能所需的功能
回答。原代T细胞中的数据表明了对特定的要求
脯氨酸介导与非受体酪氨酸激酶LCK的相互作用
通过CD28调节T细胞增殖。 PI假设多个
CD28的不同结构域调节T细胞的特定特征
激活和分化。为了解决这个问题,以下具体目标
已经提出:1)确定CD28的结构特征
原代T细胞在体外的共同刺激; 2)特定特定
CD28调节气道炎症的细胞和分子决定因素
体内。这些研究将提供有关调节T的关键数据
细胞定向免疫反应,并为
开发新的治疗策略以治疗炎症性肺
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan M. Green其他文献
Therapeutic Misdirection: An Analysis of Protocol Exception Requests in Clinical Trials
治疗误导:临床试验中协议例外请求的分析
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:1.3
- 作者:
Jonathan M. Green - 通讯作者:
Jonathan M. Green
Assessing finance for nature-based solutions to climate change
评估基于自然的气候变化解决方案的资金
- DOI:
10.51414/sei2022.052 - 发表时间:
2022 - 期刊:
- 影响因子:0.7
- 作者:
A. Atteridge;Dhyey Batpuria;Biljana Macura;Karina Barquet;Jonathan M. Green - 通讯作者:
Jonathan M. Green
Implications for Inflammatory Lung Disease
对炎症性肺病的影响
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:0
- 作者:
Jonathan M. Green - 通讯作者:
Jonathan M. Green
Coordinate Regulation of T Cell Activation by CD2 and CD281
CD2 和 CD281 对 T 细胞激活的协调调节
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:4.4
- 作者:
Jonathan M. Green;V. Karpitskiy;S. Kimzey;A. Shaw - 通讯作者:
A. Shaw
Addressing Scale in Nature-Based Solutions
解决基于自然的解决方案的规模问题
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
O. Vincent;Karina Barquet;Jonathan M. Green - 通讯作者:
Jonathan M. Green
Jonathan M. Green的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan M. Green', 18)}}的其他基金
IMMUNOLOGIC BASIS FOR SUSCEPTIBILITY TO SECONDARY INFECTIONS IN SEVERE SEPSIS
严重脓毒症继发感染易感性的免疫学基础
- 批准号:
8008689 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
IMMUNOLOGIC BASIS FOR SUSCEPTIBILITY TO SECONDARY INFECTIONS IN SEVERE SEPSIS
严重脓毒症继发感染易感性的免疫学基础
- 批准号:
8077901 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
How CD2 and CD28 Determine Susceptibility to P. Carinii
CD2 和 CD28 如何确定对卡氏疟原虫的易感性
- 批准号:
6496549 - 财政年份:2002
- 资助金额:
$ 33.59万 - 项目类别:
How CD2 and CD28 Determine Susceptibility to P. Carinii
CD2 和 CD28 如何确定对卡氏疟原虫的易感性
- 批准号:
6627834 - 财政年份:2002
- 资助金额:
$ 33.59万 - 项目类别:
COSTIMULATORY MOLECULES IN INFLAMMATORY LUNG DISEASE
炎症性肺病中的协同刺激分子
- 批准号:
8669032 - 财政年份:2000
- 资助金额:
$ 33.59万 - 项目类别:
相似海外基金
Clonal CD4 T-Cells in Lung Transplant Recipients
肺移植受者中的克隆性 CD4 T 细胞
- 批准号:
7031202 - 财政年份:2006
- 资助金额:
$ 33.59万 - 项目类别:
Analyzing and modulating immunoregulatory defects in autoimmune disease
分析和调节自身免疫性疾病的免疫调节缺陷
- 批准号:
7036311 - 财政年份:2006
- 资助金额:
$ 33.59万 - 项目类别:
Immuno-modulatory Effects of Parenteral Nutrition After Intestinal Failure
肠衰竭后肠外营养的免疫调节作用
- 批准号:
7139425 - 财政年份:2006
- 资助金额:
$ 33.59万 - 项目类别:
Visualizing regulatory T cell control of autoimmunity
调节性 T 细胞对自身免疫的控制可视化
- 批准号:
6962937 - 财政年份:2005
- 资助金额:
$ 33.59万 - 项目类别:
Plasmacytoid dendritic cell behavior in ovarian cancer
卵巢癌中的浆细胞样树突状细胞行为
- 批准号:
6989458 - 财政年份:2005
- 资助金额:
$ 33.59万 - 项目类别: